
Clin Pharmacol Ther. 2008 Sep;84(3):370-7. has an interesting article on the pharmacokinetics of enoxaparin in pregnancy. Basically, the clearance of enoxaparin greatly increases during the course of pregnancy resulting in a marked decrease in anti-Xa activity. The authors even recommend that thromboprophylaxis should be dosed to the pregnant patient's weight rather than a standard 40 mg/day.
What I find curious about this graph I trapped on my mobile phone (no online version available) is that the peak level in late pregnancy (the dark line) is the same level as the 12 hour point for non-pregnancy. Guidelines warn us off CNBs for 12 hours after 40 mg enoxaparin, but in pregnancy the anti-Xa level at the 4 hour peak is the same as when the level is presumed safe in the non-pregnant safe.
So if the parturient has recently had a standard 40 mg enoxaparin, is it reasonable to offer an epidural or spinal? If no, the poor soul will be denied the benefits of an obstetric regional analgesia/anaesthesia as well as being managed with sub-therapeutic thromboprophylaxis!